A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...
A research team has developed an AI-based personalized cancer vaccine design technology that enables long-term immunity that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback